It starts with knowledge. We employ the best minds in the business - nearly 2,000 of them - all applying their extensive industry-based scientific and regulatory expertise to your early-stage research from discovery through Phase IIa. All working together to smooth the pathway from the molecule to the deal for your compound.

It continues with a global infrastructure of facilities strategically located around the world, linked to a robust, integrated IT network with superior reliability.

MDS Pharma Services applies its advanced scientific and technological expertise through the early stages of the drug discovery and development process – from lead optimization, pre-IND research, early clinical research (bioequivalence, phases 0-IIa), bioanalysis and cardiac safety services.
It all comes together via an interconnected network of dedicated teams focused on managing your projects to meet your milestones and keep your project on track. More importantly, our capability and expertise to both customize and execute your research and development programs further accelerate your drug's development.

MDS Pharma Services has created a Drug Development Programs service that tailors our program management approach to meet the specific needs of each client, providing full program and scientific consulting, project management and program facilitation. Our Small Molecule Development Program is just one example of the versatility and scope available through Development and Regulatory Services.

From the start, MDS Pharma Services works with you as an integrated team. Our efforts are led by a senior level scientist/manager experienced in drug development who serves as the program leader. All aspects, including contracting, conduct and follow-up, are addressed through Development and Regulatory Services.